New York City - Events at Quotient Sciences

DCAT 2026: Consultants Event

New York, United States | 25 March 2026
Overview

Join Quotient Sciences and Intrepid Labs for an exclusive dinner exploring how Artificial Intelligence is transforming formulation development. 

Discover how AI platforms are accelerating development timelines, optimizing formulation strategies, and enhancing the predictability of clinical performance. Hear from our experts, Dr. Andy Lewis and Dr. Christine Allen, in an insightful presentation followed by an interactive discussion and Q&A session. Enjoy a delicious dinner, drinks, and networking opportunities with industry peers.

Date/TimeLocation
Wednesday, 25th March 2026
6:00 PM – 6:45 PM Guest registration and networking
6:45 PM Welcome remarks – Andrew Lewis 
6:45 PM – 7:30 PM AI presentation and Q&A – Andrew Lewis and Christine Allen 
7:30 PM – 8:30 PM Dinner service 
8:30 PM onward Networking and after-dinner drinks 

Empire Steak House, Tomahawk Room,

151 East 50th St. New York, NY 10022

Space is limited! Register your interest to attend our seminar. If you have any questions or difficulty registering, reach out to [email protected].

 

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register
Location
Empire Steak House, Tomahawk Room
151 East 50th St., NY 10022
New York, United States

Meet our experts:

We look forward to meeting you at DCAT 2026: Consultants Event.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Christine Allen

Co-Founder & CEO Intrepid Labs

Dr. Christine Allen is CEO and co-founder of Intrepid Labs Inc., a company leveraging AI, automation, and deep pharmaceutical expe...

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Read More
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development
Read More
Get in touch
Humanity can't afford to wait, so neither can we.